NSCLC, STAGE I
Clinical trials for NSCLC, STAGE I explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE I trials appear
Sign up with your email to follow new studies for NSCLC, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy after surgery may keep early lung cancer at bay
Disease control Recruiting nowThis study is for people with stage I non-small cell lung cancer who have had their tumor surgically removed. It compares receiving the immunotherapy drug pembrolizumab every 6 weeks for about a year versus simply being watched (observation). The goal is to see if pembrolizumab c…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Greg Durm, MD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a soy compound shield lungs from radiation damage?
Disease control Recruiting nowThis phase II trial tests whether a drug called BIO 300, made from a soy compound, can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease. About 25 participants will receive BIO 300 along wi…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC